Product References
Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer's disease.
Alzheimer's research & therapy
Rofo F,Metzendorf NG,Saubi C,Suominen L,Godec A,Sehlin D,Syvänen S,Hultqvist G
44-136 was used in Enzyme-linked immunosorbent assay to show that a one-time injection of a BBB-penetrating NEP shows the potential to reduce, the likely most toxic, Aβ oligomers in the brain in addition to monomers. Also, Aβ aggregates in the blood were reduced.
Mon Dec 05 00:00:00 EST 2022
The Impact of the hAPP695SW Transgene and Associated Amyloid-β Accumulation on Murine Hippocampal Biochemical Pathways.
Journal of Alzheimer's disease : JAD
Khorani M,Bobe G,Matthews DG,Magana AA,Caruso M,Gray NE,Quinn JF,Stevens JF,Soumyanath A,Maier CS
44-136 was used in Immunohistochemistry-immunofluorescence to suggest that dysregulation of multiple metabolic pathways associated with a concomitant shift to an excitatory-inhibitory imbalance are contributing mechanisms of Alzheimer's disease-related pathology in the Tg2576 mouse.
Thu Mar 03 00:00:00 EST 2022
Enhanced neprilysin-mediated degradation of hippocampal Aβ42 with a somatostatin peptide that enters the brain.
Theranostics
Rofo F,Ugur Yilmaz C,Metzendorf N,Gustavsson T,Beretta C,Erlandsson A,Sehlin D,Syvänen S,Nilsson P,Hultqvist G
Published figure using beta Amyloid (1-40) polyclonal antibody (Product # 44-136) in ELISA
Wed Aug 04 00:00:00 EDT 2021
Low-Dose Phosphodiesterase III Inhibitor Reduces the Vascular Amyloid Burden in Amyloid-β Protein Precursor Transgenic Mice.
International journal of molecular sciences
Yakushiji Y,Kawamoto K,Uchihashi K,Ihara M,Aoki S,Nagaishi Y,Suzuyama K,Tsugitomi Y,Hara H
44-136 was used in Immunohistochemistry to investigate whether lower-dose cilostazol can decrease micro-hemorrhages and amyloid-β (Aβ) deposition in the brain using Aβ Precursor Protein (APP) transgenic mice.
Thu Mar 26 00:00:00 EDT 2020
Low-Dose Phosphodiesterase III Inhibitor Reduces the Vascular Amyloid Burden in Amyloid-β Protein Precursor Transgenic Mice.
International journal of molecular sciences
Yakushiji Y,Kawamoto K,Uchihashi K,Ihara M,Aoki S,Nagaishi Y,Suzuyama K,Tsugitomi Y,Hara H
44-136 was used in Immunohistochemistry to investigate whether lower-dose cilostazol can decrease micro-hemorrhages and amyloid-β (Aβ) deposition in the brain using Aβ Precursor Protein (APP) transgenic mice.
Thu Mar 26 00:00:00 EDT 2020
Effects of rising amyloidβ levels on hippocampal synaptic transmission, microglial response and cognition in APPSwe/PSEN1M146V transgenic mice.
EBioMedicine
Medawar E,Benway TA,Liu W,Hanan TA,Haslehurst P,James OT,Yap K,Muessig L,Moroni F,Nahaboo Solim MA,Baidildinova G,Wang R,Richardson JC,Cacucci F,Salih DA,Cummings DM,Edwards FA
44-136 was used in Immunohistochemistry-immunofluorescence to investigate CA1 synaptic transmission and plasticity.
Tue Jan 01 00:00:00 EST 2019
Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice.
Antioxidants (Basel, Switzerland)
Matthews DG,Caruso M,Murchison CF,Zhu JY,Wright KM,Harris CJ,Gray NE,Quinn JF,Soumyanath A
44-136 was used in Immunohistochemistry to study the effect of Centella asiatica water extract treatment on oxidative stress in Alzheimer's disease model mice.
Sun Dec 08 00:00:00 EST 2019
A 4R tauopathy develops without amyloid deposits in aged cat brains.
Neurobiology of aging
Poncelet L,Ando K,Vergara C,Mansour S,Suain V,Yilmaz Z,Reygel A,Gilissen E,Brion JP,Leroy K
44-136 was used in Immunohistochemistry-immunofluorescence to demonstrate that the presence of a tau pathology in aged cat brains that develop independently of amyloid deposits.
Sun Sep 01 00:00:00 EDT 2019
Corticotropin-releasing factor overexpression gives rise to sex differences in Alzheimer's disease-related signaling.
Molecular psychiatry
Bangasser DA,Dong H,Carroll J,Plona Z,Ding H,Rodriguez L,McKennan C,Csernansky JG,Seeholzer SH,Valentino RJ
44136 was used in immunohistochemistry to discuss the role of corticotropin-releasing factor in the sex bias of some neuropsychiatric and neurodegenerative disorders
Tue Aug 01 00:00:00 EDT 2017
Evidence of Tau Hyperphosphorylation and Dystrophic Microglia in the Common Marmoset.
Frontiers in aging neuroscience
Rodriguez-Callejas JD,Fuchs E,Perez-Cruz C
44136 was used in immunohistochemistry - frozen section to evaluate cellular markers associated with neurodegenerative diseases in common marmoset (Callithrix jacchus) brains
Thu Oct 01 00:00:00 EDT 2020
Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls.
Annals of neurology
Esparza TJ,Zhao H,Cirrito JR,Cairns NJ,Bateman RJ,Holtzman DM,Brody DL
Published figure using beta Amyloid (1-40) polyclonal antibody (Product # 44-136) in Immunohistochemistry
Tue Jan 01 00:00:00 EST 2013
Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls.
Annals of neurology
Esparza TJ,Zhao H,Cirrito JR,Cairns NJ,Bateman RJ,Holtzman DM,Brody DL
Published figure using beta Amyloid (1-40) polyclonal antibody (Product # 44-136) in Immunohistochemistry
Tue Jan 01 00:00:00 EST 2013
Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrow.
The American journal of pathology
Keene CD,Chang RC,Lopez-Yglesias AH,Shalloway BR,Sokal I,Li X,Reed PJ,Keene LM,Montine KS,Breyer RM,Rockhill JK,Montine TJ
Published figure using beta Amyloid (1-40) polyclonal antibody (Product # 44-136) in Immunohistochemistry
Thu Jul 01 00:00:00 EDT 2010
SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells.
Nature cell biology
Bell RD,Deane R,Chow N,Long X,Sagare A,Singh I,Streb JW,Guo H,Rubio A,Van Nostrand W,Miano JM,Zlokovic BV
44-136 was used in Immunofluorescence in immunohistochemistry on frozen tissues to suggest that serum response factor and myocardin function as a transcriptional switch, controlling Abeta cerebrovascular clearance and Alzheimer's disease progression.
Sun Feb 01 00:00:00 EST 2009
SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells.
Nature cell biology
Bell RD,Deane R,Chow N,Long X,Sagare A,Singh I,Streb JW,Guo H,Rubio A,Van Nostrand W,Miano JM,Zlokovic BV
44-136 was used in Immunofluorescence in immunohistochemistry on frozen tissues to suggest that serum response factor and myocardin function as a transcriptional switch, controlling Abeta cerebrovascular clearance and Alzheimer's disease progression.
Sun Feb 01 00:00:00 EST 2009
Selective contrast enhancement of individual Alzheimer's disease amyloid plaques using a polyamine and Gd-DOTA conjugated antibody fragment against fibrillar Abeta42 for magnetic resonance molecular imaging.
Pharmaceutical research
Ramakrishnan M,Wengenack TM,Kandimalla KK,Curran GL,Gilles EJ,Ramirez-Alvarado M,Lin J,Garwood M,Jack CR,Poduslo JF
44-136 was used in immunohistochemistry - frozen section to describe using the F(ab')2 fragment of a monoclonal antibody raised against fibrillar human Abeta42 as a diagnostic imaging probe for AD
Fri Aug 01 00:00:00 EDT 2008
Histamine induces Egr-1 expression in human aortic endothelial cells via the H1 receptor-mediated protein kinase Cdelta-dependent ERK activation pathway.
The Journal of biological chemistry
Hao F,Tan M,Xu X,Cui MZ
Fri Oct 03 00:00:00 EDT 2008
Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.
The Journal of neuroscience : the official journal of the Society for Neuroscience
Oakley H,Cole SL,Logan S,Maus E,Shao P,Craft J,Guillozet-Bongaarts A,Ohno M,Disterhoft J,Van Eldik L,Berry R,Vassar R
Wed Oct 04 00:00:00 EDT 2006
Time-dependent reduction in Abeta levels after intracranial LPS administration in APP transgenic mice.
Experimental neurology
Herber DL,Roth LM,Wilson D,Wilson N,Mason JE,Morgan D,Gordon MN
44-136 was used in immunohistochemistry - free floating to report that activated brain glia rapidly and transiently clear diffuse Abeta deposits but not compacted fibrillar amyloid
Mon Nov 01 00:00:00 EST 2004
Efficient inhibition of beta-secretase gene expression in HEK293 cells by tRNAVal-driven and CTE-helicase associated hammerhead ribozymes.
European journal of biochemistry
Nawrot B,Antoszczyk S,Maszewska M,Kuwabara T,Warashina M,Taira K,Stec WJ
Wed Oct 01 00:00:00 EDT 2003
Efficient inhibition of beta-secretase gene expression in HEK293 cells by tRNAVal-driven and CTE-helicase associated hammerhead ribozymes.
European journal of biochemistry
Nawrot B,Antoszczyk S,Maszewska M,Kuwabara T,Warashina M,Taira K,Stec WJ
Wed Oct 01 00:00:00 EDT 2003
Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease.
Neurobiology of disease
Fagan AM,Watson M,Parsadanian M,Bales KR,Paul SM,Holtzman DM
Mon Apr 01 00:00:00 EST 2002
Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience
Hartman RE,Laurer H,Longhi L,Bales KR,Paul SM,McIntosh TK,Holtzman DM
Sun Dec 01 00:00:00 EST 2002
Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer's disease.
Journal of neurochemistry
DeMattos RB,Bales KR,Parsadanian M,O'Dell MA,Foss EM,Paul SM,Holtzman DM
Mon Apr 01 00:00:00 EST 2002
Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer's disease.
Journal of neurochemistry
DeMattos RB,Bales KR,Parsadanian M,O'Dell MA,Foss EM,Paul SM,Holtzman DM
Mon Apr 01 00:00:00 EST 2002
Passive immunization against beta-amyloid peptide protects central nervous system (CNS) neurons from increased vulnerability associated with an Alzheimer's disease-causing mutation.
The Journal of biological chemistry
Mohajeri MH,Saini K,Schultz JG,Wollmer MA,Hock C,Nitsch RM
Fri Sep 06 00:00:00 EDT 2002